Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP237647.RAX2BcVombbHFWmxU1jGQNT6cTlmx3FaRSC10fCtiCm6A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP237647.RAX2BcVombbHFWmxU1jGQNT6cTlmx3FaRSC10fCtiCm6A130_assertion type Assertion NP237647.RAX2BcVombbHFWmxU1jGQNT6cTlmx3FaRSC10fCtiCm6A130_head.
- NP237647.RAX2BcVombbHFWmxU1jGQNT6cTlmx3FaRSC10fCtiCm6A130_assertion description "[These efforts have revealed several acquired resistance mechanisms and candidates, including EGFR secondary mutations (T790M and other rare mutations), MET amplification, PTEN downregulation, CRKL amplification, high-level HGF expression, FAS-NF?B pathway activation, epithelial-mesenchymal transition, and conversion to small cell lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP237647.RAX2BcVombbHFWmxU1jGQNT6cTlmx3FaRSC10fCtiCm6A130_provenance.
- NP237647.RAX2BcVombbHFWmxU1jGQNT6cTlmx3FaRSC10fCtiCm6A130_assertion evidence source_evidence_literature NP237647.RAX2BcVombbHFWmxU1jGQNT6cTlmx3FaRSC10fCtiCm6A130_provenance.
- NP237647.RAX2BcVombbHFWmxU1jGQNT6cTlmx3FaRSC10fCtiCm6A130_assertion SIO_000772 22736441 NP237647.RAX2BcVombbHFWmxU1jGQNT6cTlmx3FaRSC10fCtiCm6A130_provenance.
- NP237647.RAX2BcVombbHFWmxU1jGQNT6cTlmx3FaRSC10fCtiCm6A130_assertion wasDerivedFrom befree-20140225 NP237647.RAX2BcVombbHFWmxU1jGQNT6cTlmx3FaRSC10fCtiCm6A130_provenance.
- NP237647.RAX2BcVombbHFWmxU1jGQNT6cTlmx3FaRSC10fCtiCm6A130_assertion wasGeneratedBy ECO_0000203 NP237647.RAX2BcVombbHFWmxU1jGQNT6cTlmx3FaRSC10fCtiCm6A130_provenance.